Press Releases | Arnold Ventures

Arnold Ventures Commends Senate on Unanimous Passage of the Affordable Prescriptions for Patients Act

07.11.2024

New Law Goes Into Effect to Strengthen The Maryland Prescription Drug Affordability Board

04.11.2023

California Selects Civica Rx as Its Insulin Manufacturing Partner

03.20.2023

Statement from Laura and John Arnold on Landmark Law to Lower Prescription Drug Prices

08.16.2022

Statement from Laura and John Arnold Following Senate Passage of the Inflation Reduction Act of 2022

08.07.2022

“It’s time to finish the job.”: Statement from Mark E. Miller on Historic Opportunity for Congress to Lower Prescription Drug Prices

06.30.2022

Statement from Mark E. Miller on New Insulin Legislation Offered in Senate

06.23.2022

Arnold Ventures’ Statement on the Removal of Drug Pricing from the Build Back Better Framework

10.28.2021

Arnold Ventures’ Statement on the Elijah E. Cummings Lower Drug Costs Now Act

04.22.2021

John Arnold Statement on the Passage of HR 3, Lower Drug Costs Now Act of 2019

12.12.2019

Arnold Ventures Statement on Energy and Commerce Committee Passage of Six Drug Pricing Bills

04.04.2019

Arnold Ventures’ Mark Miller Testifies Before Senate Committee on Finance

01.30.2019

Three Foundations Commit $30 Million to Civica Rx in Effort to Address Drug Shortages, High Prices

09.06.2018

Laura and John Arnold Foundation Launches Effort to Address Issue of Rising Health System Prices

08.29.2018

Mark E. Miller to Join Laura and John Arnold Foundation as Vice President of Health Care

11.03.2017

Arnold Foundation Announces $3.6M Grant to Increase Clinical Trial Transparency

05.17.2016

Arnold Foundation Announces $7.2M in Grants to Address Rising Cost of Pharmaceutical Drugs

02.17.2016

ICER Launches New Drug Assessment Program With $5.2M From Arnold Foundation

07.21.2015